Sign in
8-K

Current Report

Keros Therapeutics, Inc. Filed Acc 0001664710-23-000036

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading kros-20230606.htm…